Mahendhar Reddy Doma

Title: Mahendhar Reddy Doma: Innovator in Anticancer Research

Introduction

Mahendhar Reddy Doma is a notable inventor based in Jammu Tawi, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel anticancer agents. His innovative work has led to the creation of a unique patent that showcases his expertise and dedication to cancer research.

Latest Patents

Mahendhar Reddy Doma holds a patent for "Spiro derivatives of parthenin as novel anticancer agents." This invention involves the preparation of spiro derivatives of parthenin through the dipolar cycloaddition of various dipoles, including benzonitrile oxides, nitrones, azides, and others. The representative compounds have been screened for their anticancer activity against different cancer cell lines, with IC50 values ranging from 4.3 µM to 93 µM. The research highlights the importance of the α,β-unsaturated ketonic moiety in parthenin, which plays a crucial role in maintaining high levels of cytotoxicity.

Career Highlights

Mahendhar Reddy Doma is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research in the field of anticancer agents. His work has garnered attention for its potential impact on cancer treatment and therapy.

Collaborations

He has collaborated with notable colleagues, including Mahabalarao Sampath Kumar Halmuthur and Ajit Kumar Saxena, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Mahendhar Reddy Doma's contributions to the field of anticancer research through his innovative patents exemplify the importance of scientific inquiry in addressing critical health challenges. His work not only advances the understanding of cancer treatment but also inspires future research in medicinal chemistry.